Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2026-02-07 @ 5:29 AM
Study NCT ID:
NCT01349660
Status:
COMPLETED
Last Update Posted:
2020-06-17
First Post:
2011-04-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme
Sponsor:
SCRI Development Innovations, LLC
Organization: